hero-logo-image

Zydus Family of Drug Eluting Stents

Our coronary stent systems represent the combination of advanced material science, proprietary drug-polymer technology, and precision manufacturing, to meet the demands of modern interventional cardiology. Our portfolio includes next-generation drug-eluting stents featuring thin strut platforms for enhanced deliverability and minimal vessel trauma, alongside biodegradable polymer systems designed to optimize drug kinetics and endothelial recovery.

NOVUS – Sirolimus Eluting Coronary Stent System 

Engineered for Precision. Designed to deliver with ease. 

1

Ultra-low crossing profile for seamless navigation in tortuous vessels 

2

Proprietary U-Link + sinusoidal open-cell design ensures uniform expansion and minimal foreshortening 

3

Ultra thin strut with ultra thin biodegradable polymer coating enhances healing

4

Highly deliverable stent design for complex anatomies

novus-section-1
novus-section-1
5

Robust over-expansion capacity without coating disruption 

6

Controlled sirolimus release profile supports rapid endothelialisation 

7

High radial strength without compromising deliverability 

SIROMOUNT – Sirolimus Eluting Coronary Stent System

Designed for Excellence

1

Ultra-thin strut thickness with variable strut width for optimal flexibility and strength

2

High radial strength enables secure deployment

3

Superior polymer-matrix adhesion ensures uniform drug release

Siromount.svg
innerimage1.svginnerimage2.svginnerimage3.svgimage (3).svg
4

Low recoil rate prevents malposition

5

Wide size matrix supports treatment of short to very long lesions

6

Radiopaque markers for accurate positioning under fluoroscopy

EVERMAX – Everolimus Eluting Coronary Stent System 

Designed for Superior Performance.

1

Beam-strength optimized design with wider struts for unmatched radial support 

2

Cobalt-chromium platform with variable strut width

3

Over-expansion capability without compromise to coating or structural integrity

4

Everolimus dosage of 1.20 µg/mm² tailored for effective drug delivery and vascular healing

evermax-right-image.svg
Evermax.svg
5

Ideal for long, diffused lesions, minimizing stent overlap and associated risks  

6

Uniform coating thickness preserves polymer stability during expansion 

7

Exceptional radiopacity for confident navigation and deployment 

ENCRUSO – Everolimus Eluting Coronary Stent System  

Designed for Complexity

1

Open-cell design allows side branch access in bifurcation and complex lesions

2

Ultra-low crossing profile (0.037") aids deliverability in highly tortuous anatomies

3

Ultrathin strut thickness with biodegradable PLLA+PLGA polymer coating

4

Proprietary U-Link structure minimizes recoil and maximizes conformability

ENCRUSO-right-image.svg
ENCRUSO-left-image.svg
5

Minimal balloon overhang (<0.5 mm) enhances precision in stent placement 

6

Advanced surface polish reduces endothelial damage during deployment 

7

Stable platform performance validated through internal recoil and expansion testing